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Non-healing cutaneous wounds are commonly associated 
with dysregulation of the zinc-dependent matrix metal-
loproteinases (MMPs) (1). MMP-8 is the most efficient 
human collagenase and degrades collagens synergistically 
with MMP-9 (2, 3). Although MMP-8 and MMP-9 are 
necessary for normal wound healing, their excessive 
expression impairs experimental wound healing (3–6).
Elevated MMP-8 and MMP-9 levels were found in 
colonized venous leg ulcers (VLUs) compared with sterile 
split-thickness skin graft (STSG) donor sites in patients 
with VLUs. Polymorphonuclear leukocytes (PMNs) are 
the major sources of MMP-8 and MMP-9 in VLUs (7). 
These MMPs are pre-formed and stored in the secondary 
(8) and tertiary (9) granules of mature PMNs. It was 
hypothesized that the presence of bacteria results in a 
species-specific increase in MMP-8 and MMP-9 levels 
by stimulating degranulation of PMNs and promoting the 
conversion of catalytically inactive MMPs to their active 
forms via bacterial-derived proteinases. Staphylococcus 
aureus and Pseudomonas aeruginosa were studied here 
as prototypic wound pathogens (10).
MATERIALS AND METHODS (see Appendix S11)
RESULTS
Human PMNs were exposed to sterile-filtered supernatants from 
S. aureus and P. aeruginosa grown under static biofilm condi-
tions. The PMN viability (> 70%) was similar in the control and 
treatment groups, and the mean ± standard deviation [SD] total 
MMP-8 content in 106 PMNs from the 4 donors was 39 ± 2.4 ng 
(8). S. aureus supernatants increased (p < 0.00050) the release of 
MMP-8 from the PMNs (Fig. 1a); the release with the highest titre 
was 62 ± 5.5%, which was higher than the middle titre (30 ± 9.9%, 
p = 0.0010) and the control (17 ± 6.9%, p < 0.00050). P. aeruginosa 
supernatants had a modest effect (p = 0.041) with an increased 
MMP-8 release with the highest titre (20 ± 8.1%) compared 
with the control (8.9 ± 4.6%, p = 0.040), but not compared with 
the middle titre (12 ± 2.5%, p = 0.75). The secretagogue phorbol 
12-myristate 13-acetate (100 ng/ml) caused a release of 81 ± 2.6% 
compared with 3.8 ± 1.0% for the Krebs-Ringer balanced salt solu-
tion with 10 mM glucose control (8). No MMP-8 was detected 
in the bacterial supernatants with the ELISA assay. To ascertain 
whether the bacteria were capable of activating MMP-8, PMN 
media and cell lysates were analysed with Western blot. Prominent 
bands corresponding to active PMN-derived MMP-8 were obser-
ved in the media from S. aureus-treated PMNs (Fig. 1b, c) and in 
VLU wound fluids (lane 5, Fig. 1c).  In contrast, minimal active 
MMP-8 was observed in sterile STSG donor site wound fluids (lane 
6, Fig. 1c). S. aureus alone produced a protein (~65 kDa) that was 
recognized by the monoclonal antibody at the position of human 
active PMN-derived MMP-8 and remained unaltered by reduction 
(lanes 2, 7 and 8, Fig. 1c). Staphylococcus aureus strains can make 
7 serine proteinases (SspA and SplA-F), 2 cysteine proteinases 
(ScpA and SspB), and a single metalloproteinase (Aur) (13). This 
protein was unlikely to be a metalloproteinase (Fig. 1d). Thus, we 
were unable to conclude whether S. aureus products activate latent 
PMN-derived MMP-8. 
In accordance with the MMP-8 findings, S. aureus products sti-
mulated the exocytosis of MMP-9, while P. aeruginosa mitigated 
the MMP-9 levels in media. Judged by the zymographic analysis, 
MMP-9 released from the PMNs was latent. The 2 gelatinolytic 
bands only observed in lanes 6 and 7 in Fig. 1e presumably cor-
respond to the action of LasB complex and AprA metalloprotei-
nases produced by P. aeruginosa (14). 
DISCUSSION
This study demonstrated that bacterial products exert a 
major impact on the release of MMP-8 and MMP-9 from 
immune cells present in wounds. These effects appear to 
be species-dependent, and S. aureus biofilm supernatants 
increased MMP-8 and MMP-9 release from human PMNs, 
while P. aeruginosa appeared to decrease the medium 
levels of these MMPs. This study was unable to explain 
the discrepancy between the ELISA and the Western blot 
measurements of MMP-8. Nevertheless, the increased de-
granulation of PMNs may contribute to the elevated MMP-
8 and MMP-9 levels in wounds with bacterial biofilms.
For our initial important findings to be translated to the 
microenvironment of wounds, they should be expanded 
by including a wide range of different clinical isolates. 
Furthermore, because the wound microbiota is commonly 
polymicrobial, the combined effect of different bacterial 
cell types should be evaluated (10). In these experiments, 
the effects of products produced by bacteria grown under 
various conditions and modes (planktonic growth vs bio-
film formation) ought to be assessed. Supernatants from 
PAO1 grown in a TSB medium with agitation activated 
latent MMP-9 produced by epithelial cells (15).
The results of this study suggest that the interpatient 
variations in MMP-8 and MMP-9 levels and the degree of 
activation can, at least in part, be ascribed to differences 
in the microbiota of wounds.
Staphylococcus aureus Augments Release of Matrix Metalloproteinase-8 from Human Polymorpho-
nuclear Leukocytes
Klaus KIRKETERP-MØLLER1 , Thomas BJARNSHOLT2,3 , Peter Østrup JENSEN2–4  and Magnus S. ÅGREN1,5,6
1Copenhagen Wound Healing Center and 5Digestive Disease Center, Bispebjerg Hospital, Bispebjerg Bakke 23, DK-2400 Copenhagen 
NV, 2Costerton Biofilm Center, Department of Clinical Immunology and Microbiology, University of Copenhagen, 3Department of Clinical 
Microbiology, Rigshospitalet, 4Institute for Inflammation Research, Center for Rheumatology and Spine Diseases, Copenhagen University 
Hospital, Rigshospitalet, Copenhagen, Denmark, and 6Department of Clinical Medicine, Faculty of Health and Medical Sciences, University 
of Copenhagen, Copenhagen, Denmark. E-mail: kkm@dadlnet.dk
Accepted Jun 23, 2020; Epub ahead of print Jul 3, 2020
1https://www.medicaljournals.se/acta/content/abstract/10.2340/00015555-3582
A
ct
aD
V
A
ct
aD
V
A
d
v
a
n
c
e
s 
in
 d
e
rm
a
to
lo
g
y
 a
n
d
 v
e
n
e
re
o
lo
g
y
A
c
ta
 D
e
rm
a
to
-V
e
n
e
re
o
lo
g
ic
a
Short communication2/2
www.medicaljournals.se/acta
ACKNOWLEDGEMENTS
The authors thank Omid Niazi, Vibeke Pless, Anne Kirstine 
Nielsen and Marjan Yousefi for their expert technical assistance.
The authors have no conflicts of interest to declare.
REFERENCES
1. Krishnaswamy VR, Mintz D, Sagi I. Matrix metalloproteinases: 
the sculptors of chronic cutaneous wounds. Biochim Biophys 
Acta Mol Cell Res 2017; 1864: 2220–2227.
2. Ågren MS, Andersen TL, Mirastschijski U, et al. Action of 
matrix metalloproteinases at restricted sites in colon anas-
tomosis repair: an immunohistochemical and biochemical 
study. Surgery 2006; 140: 72–82.
3. Danielsen PL, Holst AV, Maltesen HR, et al. Matrix metallo-
proteinase-8 overexpression prevents proper tissue repair. 
Surgery 2011; 150: 897–906.
4. Gutiérrez-Fernandez A, Inada M, Balbín M, et al. Increased 
inflammation delays wound healing in mice deficient in col-
lagenase-2 (MMP-8). FASEB J 2007; 21: 2580–2591.
5. Reiss MJ, Han YP, Garcia E, Goldberg M, Yu H, Garner WL. 
Matrix metalloproteinase-9 delays wound healing in a murine 
wound model. Surgery 2010; 147: 295–302.
6. Kyriakides TR, Wulsin D, Skokos EA, et al. Mice that lack 
matrix metalloproteinase-9 display delayed wound healing 
associated with delayed reepithelization and disordered col-
lagen fibrillogenesis. Matrix Biol 2009; 28: 65–73.
7. Zillmer R, Trøstrup H, Karlsmark T, Ifversen P, Ågren MS. 
Duration of wound fluid secretion from chronic venous leg 
ulcers is critical for interleukin-1α, interleukin-1β, interleu-
kin-8 levels and fibroblast activation. Arch Dermatol Res 
2011; 303: 601–606.
8. Owen CA, Hu Z, Lopez-Otin C, Shapiro SD. Membrane-bound 
matrix metalloproteinase-8 on activated polymorphonuclear 
cells is a potent, tissue inhibitor of metalloproteinase-resistant 
collagenase and serpinase. J Immunol 2004; 172: 7791–7803.
9. Borregaard N, Lollike K, Kjeldsen L, et al. Human neutrophil 
granules and secretory vesicles. Eur J Haematol 1993; 51: 
187–198.
10. Gjødsbøl K, Christensen JJ, Karlsmark T, Jørgensen B, Klein 
BM, Krogfelt KA. Multiple bacterial species reside in chronic 
wounds: a longitudinal study. Int Wound J 2006; 3: 225–231.
11. Trøstrup H, Holstein P, Karlsmark T, Moser C, Ågren MS. 
Uncontrolled gelatin degradation in non-healing chronic 
wounds. J Wound Care 2018; 27: 724–734.
12. Ågren MS, Schnabel R, Christensen LH, Mirastschijski U. 
Tumor necrosis factor-alpha-accelerated degradation of type 
I collagen in human skin is associated with elevated matrix 
metalloproteinase (MMP)-1 and MMP-3 ex vivo. Eur J Cell 
Biol 2015; 94: 12–21.
13. Mootz JM, Malone CL, Shaw LN, Horswill AR. Staphopains 
modulate Staphylococcus aureus biofilm integrity. Infect 
Immun 2013; 81: 3227–3238.
14. Schmidtchen A, Wolff H, Hansson C. Differential proteinase 
expression by Pseudomonas aeruginosa derived from chronic 
leg ulcers. Acta Derm Venereol 2001; 81: 406–409.
15. de Bentzmann S, Polette M, Zahm JM, et al. Pseudomonas 
aeruginosa virulence factors delay airway epithelial wound 
repair by altering the actin cytoskeleton and inducing overac-
tivation of epithelial matrix metalloproteinase-2. Lab Invest 
2000; 80: 209–219.
Fig. 1. Effect of supernatants from Staphylococcus aureus and Pseudomonas aeruginosa biofilms on polymorphonuclear leukocytes (PMNs) 
release of matrix metalloproteinase (MMP)-8 and MMP-9. (a) MMP-8 in PMN media measured by enzyme-linked immunoassay (ELISA) in % of 
the total MMP-8 content from 4 healthy donors. Horizontal bars indicate median values. (b) Western blot MMP-8 analysis of 8 µl media (M: 4, 6, 8, 10, 
12, 14) and 8 µl cell lysate (C: 5, 7, 9, 11, 13, 15) of PMNs (1 donor) treated with S. aureus (lanes 4–9) or P. aeruginosa (lanes 10–15) supernatants. 
Standards: 5 ng rhMMP-8 (908-MP; R&D Systems, Minneapolis, MN, USA) activated with 1 mM 4-aminophenylmercuric acetate (APMA) for 1 h at 37°C 
(lane 2) or not (lane 1); spontaneously activated human PMN-derived MMP-8 (lane 3). (c) Western blot MMP-8 analysis. Lanes 1 and 3, media of PMNs 
treated with S. aureus (SA) supernatant (50×106 colony-forming units (CFU)/ml) activated with APMA (lane 3) or not (lane 1); 2, S. aureus supernatant 
(50×106 CFU/ml); 4, spontaneously activated human PMN-derived MMP-8; 5, 125 nl VLU wound fluid; 6, 250 nl split-thickness skin graft (STSG) donor 
site wound fluid (11); 7 and 8, S. aureus (SA) supernatant (250×106 CFU/ml) treated with dithiothreitol (DTT) for 5 min at 95°C (lane 8) or not (lane 
7); lane 9, 2 ng rhMMP-8 (RayBiotech). (d) Casein zymographic analysis (inverse image) of S. aureus (SA) supernatant (amount loaded corresponded to 
1×107 CFU) in lane 3. Standards: 10 ng rhMMP-1 (12) in lane 1 and 100 ng APMA-activated rhMMP-8 in lane 2. (e) Gelatin zymography (inverse image) 
of 4 µl media as analysed in (b). NGAL (neutrophil gelatinase-associated lipocalin)/MMP-9 complex. Standard: 1 µg rhMMP-9 (lane 1). (b–e) Positions 
of molecular weight standards, in kDa, are indicated to the left.
